Clinical and behavioral characteristics of adults receiving medical care for HIV infection- medical monitoring project, United States, 2007

Morbidity and Mortality Weekly Report

Volumn 60, Issue SS-11, 2011, Pages 1-18

  Blair, Janet M ^a   McNaghten, A D ^a   Frazier, Emma L ^a   Skarbinski, Jacek ^a   Huang, Ping ^b   Heffelfinger, James D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NORTHROP GRUMMAN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE MANAGEMENT; CD4 LYMPHOCYTE COUNT; COUNSELING; FEMALE; HEALTH BEHAVIOR; HEALTH CARE QUALITY; HEALTH SURVEY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSURANCE; MALE; MIDDLE AGED; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; SEXUAL BEHAVIOR; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTI-RETROVIRAL AGENTS; CASE MANAGEMENT; CD4 LYMPHOCYTE COUNT; COUNSELING; FEMALE; HEALTH BEHAVIOR; HIV INFECTIONS; HUMANS; INSURANCE COVERAGE; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POPULATION SURVEILLANCE; QUALITY OF HEALTH CARE; RISK-TAKING; SEXUAL BEHAVIOR; UNITED STATES; YOUNG ADULT;

EID: 80052603839     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. CDC. Diagnoses of HIV infection and AIDS in the United States and dependent areas, 2009. HIV Surveillance Report, 2009: vol. 21. Atlanta, GA: CDC; 2011. Available at http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/index.htm. Accessed June 10, 2011.
2. Nakashima AK, Fleming PL. HIV/AIDS surveillance in the United States, 1981-2001. J Acquir Immune Defic Syndr 2003;32(Suppl 1): S68-S85.
3. CDC. Clinical and behavioral characteristics of adults receiving medical care for HIV infection: Medical Monitoring Project, 2005 pilot data collection cycle. HIV Special Surveillance Report: no. 6. Atlanta, GA: CDC; 2010. Available at http://www.cdc.gov/hiv/topics/surveillance/resources/reports. Accessed June 10, 2011.
4. Institute of Medicine. Measuring what matters: allocation, planning and quality assessment for the Ryan White CARE Act. Washington, DC: National Academies Press; 2004. Available at https://download.nap.edu/catalog.php?record_id=10855. Accessed June 10, 2011.
5. McNaghten AD, Wolfe MI, Onorato I, et al. Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach. PloS ONE 2007;2:e550.
6. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
7. Donnell D, Baeten J, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375:2092-8.
8. White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States. Washington, DC: The White House; 2010. Available at http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf. Accessed June 10, 2011.
9. Althoff KN, Gange SJ, Klein MB, et al. Late Presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis 2010;50:1512-20.
10. Reed JB, Hanson D, McNaghten AD, et al. HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000-2004. AIDS Patient Care STDs 2009;23:765-73.
11. Turner BJ, Cunningham WE, Duan N, et al. Delayed medical care after diagnosis in a U.S. national probability sample of persons infected with human immunodeficiency virus. Arch Intern Med 2000;160:2614-22.
12. Torian LV, Wiewel EW, Liu K, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med 2008;168:1181-7.
13. Fleming PL, Byers RH, Sweeney PA, Daniels D, Karon JM, Janssen RS. HIV prevalence in the United States [Abstract 11]. 9th Conference on Retroviruses and Opportunistic Infections. February 24-28, 2002; Seattle, WA.
14. Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS 2001;15:77-85.
15. Samet JH, Freedberg KA, Stein MD, et al. Trillion virion delay time from testing positive for HIV to presentation for primary care. Arch Intern Med 1998;158:734-40.
16. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington, DC: US Department of Health and Human Services; 2011 Available at http://www.aidsinfo.nih.gov/contentfiles/adultandadolescentgl.pdf. Accessed June 10, 2011.
17. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2009;49:651-81.
18. CDC. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, The Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Asociation of the Infectious Diseases Society of America. MMWR 2003; 52(No. RR-12).
19. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17.
20. Mannheimer SB, Morse E, Matts JP, et al. Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial. J Acquir Immune Defic Syndr 2006;43(Suppl 1):S41-7.
21. CDC. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2009;58(No. RR-4).
22. Althoff KN, Anastos K, Nelson KE, et al. Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons. Prev Med 2010;50:223-9.
23. Gallagher KM, Juhasz M, Harris NS, Teshale EH for the Adult and Adolescent Spectrum of HIV Disease Group Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002. J Infect Dis 2007;196:339-46.
24. Durham MD, Buchacz K, Armon C, et al; HOPS Investigators. Rates and correlates of influenza vaccination among HIV-infected adults in the HIV Outpatient Study (HOPS), USA, 1999-2008. Prev Med 2011. Epub May 4, 2011. Available at http://www.sciencedirect.com/science/article/pii/S009174351100168X. Accessed July 19, 2011.
25. Katz MH, Cunningham WE, Fleishman JA, et al. Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons. An Intern Med 135(8 Pt 1):557-565.
26. Lo W, MacGovern T, Bradford J. Association of ancillary services with primary care utilization and retention for patients with HIV/AIDS. AIDS Care 2002;14(Suppl 1):S45-S57.
27. Sherer R, Stieglitz K, Narra J, et al. HIV multidisciplinary teams work: Support services improve access to and retention in HIV primary care. AIDS Care 2002;14 (Suppl 1):S31-S44.
28. Chin JJ, Botsko M, Behar E, Finkelstein R. More than ancillary: HIV social services, intermediate outcomes and quality of life. AIDS Care 2002;21:1289-97.
29. Fisher JD, Smith LR, Lenz EM. Secondary prevention of HIV in the United States: past, current, and future perspectives. J Acquir Immune Defic Syndr 2010;55:S106-S15.
30. Stein M, Herman DS, Trisvan E, Pirraglia P, Engler P, Anderson BJ. Alcohol use and sexual risk behavior among human immunodeficiency virus-positive persons. Alcohol Clin Exp Res 2005;29:837-843.
31. Purcell DW, Parsons JT, Halkitis PN, Mizuno Y, Woods WJ. Substance use and sexual transmission risk behavior of HIV-positive men who have sex with men. J Subst Abuse 2001;13:185-200.
32. Campsmith, ML, Nakashima AK, Jones JL. Association between crack cocaine use and high-risk sexual behaviors after HIV diagnosis. J Acquir Immune Defic Syndr 2000;25:192-198.
33. Rondinelli AJ, Ouellet LJ, Strathdee SA, et al. Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend 2009;104:167-174.
34. Celentano DD, Lucas G. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues. Clin Infect Dis 2007;45(Suppl 4):S318-S323.
35. Bruce RD, Altice FL. Clinical care of the HIV-infected drug user. Infect Dis Clin North Am 2007;21:149-179,
36. Nijhawan A, Kim S, Rich JD. Management of HIV infection in patients with substance use problems. Curr Infect Dis Rep 2008;10:432-8.
37. Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania and Trinidad: a randomised trial. Lancet 2000;256:103-112.
38. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005;39:446-453.
39. CDC. Update: barrier protection against HIV infection and other sexually transmitted diseases. MMWR 1993;42:589-591.
40. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002;1: CD003255.
41. Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 2002;29:38-43.